Venlafaxine Hydrochloride recalls
Venlafaxine Hydrochloride products have been recalled 4 times, most recently on 31 Jul 2024. The recalling company is usually Zydus Pharmaceuticals USA. The most common reason is potency & assay.
Total recalls4since 2016
Last 12 months0reported
Class I00% of total
Ongoing0latest 31 Jul 2024
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 4 100%Class III 0 0%
Why venlafaxine hydrochloride is recalled
Companies
Product types
By year
All venlafaxine hydrochloride recalls, newest first
4 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Venlafaxine Hydrochloride Extended-Release Capsules, USP 5mg recalledVenlafaxine Hydrochloride | Zydus Pharmaceuticals (USA) | Potency & Assay | Nationwide |
| Drug | CLASS II | Venlafaxine Hydrochloride extended release capsules, 5 mg recalledVenlafaxine Hydrochloride | Aurobindo Pharma USA | Other | Nationwide |
| Drug | CLASS II | Venlafaxine HCL ER Capsule USP, 75mg recalledVenlafaxine Hydrochloride | Zydus Pharmaceuticals USA | Potency & Assay | Nationwide |
| Drug | CLASS II | Venlafaxine HCL ER Capsule USP, 150mg recalledVenlafaxine Hydrochloride | Zydus Pharmaceuticals USA | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.